HPVITS2026-058: Pharmaceutical Products
Upcoming Tender
Market release date: 30 Jan 2026
Option periods: 2 x 2yrs
Description
Contract for the provision of a range of pharmaceutical products to Victorian public health services.Additional information
Update: 25 November 2024
HPVITS2026-058 Pharmaceutical Products - Request For Information (RFI)
HealthShare Victoria is exploring the market for pharmaceutical products in order to
- Assess the potential of any new pharmaceutical products, primarily generics, being introduced to the Australian market
- Inform future procurement activity strategy and scope are fit for purpose
The Pharmaceutical Products category is focused on medications required in a public hospital setting.
Release Date: 25 November 2024, 16:00 pm AEDT (Melbourne Time)
Closing Date: 6 December 2024, 14:00pm AEDT (Melbourne Time)
Intended scope:
Scope Inclusions: Pharmaceutical products, biopharmaceuticals
Scope Exclusions: IV Fluids, Total Parenteral Nutrition, Contrast Media, Compounded Chemotherapy, Radiopharmaceuticals
Important Notes:
- A formal market approach will be released at a later stage
- Response to this RFI is optional. Suppliers not submitting a response will be able to submit a response to future market approach.
- Any response to this RFI will be subject to HSV policies & procedures.
- Please ‘Favourite’ the relevant contract ‘HPVITS2026-058 Pharmaceutical Products’ to receive communication updates for this category.
Please direct all correspondence through the messaging function in the HSV Procurement Portal.
Useful information:
1. To subscribe and receive contract update notifications, favourite this contract cabinet.
2. Review your account settings to ensure the notification frequency selected is adequate.
3. Information for Prospective Suppliers can be found on our website: https://healthsharevic.org.au/tenders-and-contracts/information-for-new-suppliers/prospective-suppliers/